Navigation Links
Global Intravenous (IV) Iron Drugs Industry
Date:6/1/2011

NEW YORK, June 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Intravenous (IV) Iron Drugs Industry

http://www.reportlinker.com/p0305172/Global-Intravenous-IV-Iron-Drugs-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 18 companies including many key and niche players such as AMAG Pharmaceuticals, Inc., Fresenius Medical Care AG & Co. KGaA, Galenica Ltd., Vifor Pharma Ltd., Luitpold Pharmaceuticals, Inc., American Regent, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., Sanofi-Aventis U.S. LLC, Syner-Med (Pharmaceutical Products) Ltd., and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

INTRAVENOUS (IV) IRON DRUGS MCP-6464

A GLOBAL MARKET REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions an
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
2. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
3. Reportlinker Adds Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4. Reportlinker Adds Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
6. VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia
7. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
8. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
9. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
10. Amicus Therapeutics to Present at Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011
11. Derycz Scientific Hires AstraZeneca Executive to Drive Global Sales Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that Sanofi ... and license agreement for Ardelyx,s portfolio of NaP2b ... payment associated with termination and the return of ... Sanofi entered into an option and license agreement ...
(Date:9/1/2015)... 1, 2015 Emerus Holdings, a national ... inpatient and diagnostic care in partnership with leading ... definitive agreement to receive a strategic investment from ... leading health care investment firm. Emerus ... acute episodic and ambulatory clinical services to communities ...
(Date:9/1/2015)... --  Alpha Imaging LLC , a leading distributor of advanced medical ... that they have been awarded exclusive rights to represent the complete ... new territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities ... , Indiana , Pennsylvania , ... West Virginia , Delaware and ...
Breaking Medicine Technology:Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3Alpha Imaging Expands Shimadzu Territory 2
... at Brigham and Women,s,Hospital found that patients taking cannabinoid ... were unrelated to relief from their pain,symptoms. Results ... the addictive,potential of this class of pain medicine, were ... Annual Meeting. , In the ...
... The Netherlands, January 28 ,Amsterdam Molecular Therapeutics ... of,human gene therapy, announced today during the ... showing that one treatment of its lead ... and clinically important,lowering of the incidence of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 3
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and ... hormone-free treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... monitoring and analysis of pet vital signs and activity, today announced its integration ... of the most popular and widely-adopted veterinary hospital Practice Management Software packages in ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned ... men and women for 19 years and found that, among those who had a ... , The report is part of the September 2015 issue of “Natural Insights for ...
(Date:9/1/2015)... ... ... Two of Washington D.C.’s most respected chefs are using their global expertise ... named “the next big thing” in the culinary world by Elle Spain, award-winning culinary ... food and reclaiming culinary traditions on the brink of extinction. According to Amy and ...
(Date:9/1/2015)... ... 01, 2015 , ... METTLER TOLEDO is pleased to announce ... Connectivity Kit, EasySampler data is automatically transferred to, and reported with, the referring ... platform. , EasySampler fully automates the sampling process including sampling capture, ...
Breaking Medicine News(10 mins):Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3
... 30% in 2007, ... to Millennium Research Group, WALTHAM, Mass., Feb. 25 ... or equal to 3.0 mm),dental implants are becoming increasingly popular ... faster rate than those of regular-diameter,(> 3.0 mm) dental implants., ...
... anxious about their skin condition say they are less likely ... at the University of Bath (UK). , The study, published ... middle-aged adults recruited from a national acne support group. , ... participate in sport or exercise, acne sufferers who perceived their ...
... Aware,s AccuRad client/server software suite enables remote browser-based, ... bandwidth-constrained network, BEDFORD, Mass., Feb. 25 ... and biometrics software, today,announced it will showcase the ... the 2008 Annual HIMSS Conference & Exhibition. HIMSS08,is ...
... Inc. (OTC Bulletin,Board: IAGX), announced today that the ... Committee has selected Celadrin(R),Topical Cream as its Official ... provide the best medical care for the athletes ... has expanded its goal to provide the most,advanced ...
... 25, 2008 A vaginal microbicide that incorporates an antiretroviral ... safe for sexually active HIV-negative women to use every day ... of tenofovir topical gel. Moreover, most of the women who ... States adhered to a regimen involving either daily or sex-dependent ...
... (Nasdaq:,LCAV), a leading provider of laser vision correction services ... vision center in Des,Moines, Iowa. This marks the 74th ... LasikPlus vision center in the state of Iowa.,LasikPlus vision ... markets., Similar to other LasikPlus vision centers throughout ...
Cached Medicine News:Health News:Small-Diameter Dental Implants Increasingly Popular In the US 2Health News:Acne may prevent people from participating in sport and exercise, says research 2Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 2Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 3Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 4Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 5Health News:International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as it's First and Only Official Joint and Muscle Topical Cream 2Health News:International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as it's First and Only Official Joint and Muscle Topical Cream 3Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 2Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 3Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 4Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 5Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 6Health News:LCA-Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines, Iowa 2
Used to negotiate tortuous vessels....
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Medicine Products: